journal article·2024-09Open access

Binary fabrication of decellularized lung extracellular matrix hybridgels for in vitro chronic obstructive pulmonary disease modeling

Leigh-Ann M. Antczak, Karah N. Moore, Taylor E. Hendrick, Rebecca L. Heise

Acta Biomaterialia· Volume 185

Abstract

Limited treatments and a lack of appropriate animal models have spurred the study of scaffolds to mimic lung disease in vitro. Decellularized human lung and its application in extracellular matrix (ECM) hydrogels has advanced the development of these lung ECM models. Controlling the biochemical and mechanical properties of decellularized ECM hydrogels continues to be of interest due to inherent discrepancies of hydrogels when compared to their source tissue. To optimize the physiologic relevance of ECM hydrogel lung models without sacrificing the native composition we engineered a binary fabrication system to produce a Hybridgel composed of an ECM hydrogel reinforced with an ECM cryogel. Further, we compared the effect of ECM-altering disease on the properties of the gels using elastin poor Chronic Obstructive Pulmonary Disease (COPD) vs non-diseased (ND) human lung source tissue. Nanoindentation confirmed the significant loss of elasticity in hydrogels compared to that of ND human lung and further demonstrated the recovery of elastic moduli in ECM cryogels and Hybridgels. These findings were supported by similar observations in diseased tissue and gels. Successful cell encapsulation, distribution, cytotoxicity, and infiltration were observed and characterized via confocal microscopy. Cells were uniformly distributed throughout the Hybridgel and capable of survival for 7 days. Cell-laden ECM hybridgels were found to have elasticity similar to that of ND human lung. Compositional investigation into diseased and ND gels indicated the conservation of disease-specific elastin to collagen ratios. In brief, we have engineered a composited ECM hybridgel for the 3D study of cell-matrix interactions of varying lung disease states that optimizes the application of decellularized lung ECM materials to more closely mimic the human lung while conserving the compositional bioactivity of the native ECM. STATEMENT OF SIGNIFICANCE: The lack of an appropriate disease model for the study of chronic lung diseases continues to severely inhibit the advancement of treatments and preventions of these otherwise fatal illnesses due to the inability to recapture the biocomplexity of pathologic cell-ECM interactions. Engineering biomaterials that utilize decellularized lungs offers an opportunity to deconstruct, understand, and rebuild models that highlight and investigate how disease specific characteristics of the extracellular environment are involved in driving disease progression. We have advanced this space by designing a binary fabrication system for a ECM Hybridgel that retains properties from its source material required to observe native matrix interactions. This design simulates a 3D lung environment that is both mechanically elastic and compositionally relevant when derived from non-diseased tissue and pathologically diminished both mechanically and compositionally when derived from COPD tissue. Here we describe the ECM hybridgel as a model for the study of cell-ECM interactions involved in COPD.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Provisional Mortality Data — United States, 202210.15585/mmwr.mm7218a3 ↗
2. Effects of extracellular matrix viscoelasticity on cellular behaviour
3. Lung extracellular matrix and fibroblast function10.1513/AnnalsATS.201406-240MG ↗
4. Extracellular matrix plasticity as a driver of cell spreading10.1073/pnas.2008801117 ↗
5. The extracellular matrix – the under-recognized element in lung disease?10.1002/path.4808 ↗
6. Limitation of COPD studies in animal modeling
7. Microarray analyses to quantify advantages of 2D and 3D hydrogel culture systems in maintaining the native valvular interstitial cell phenotype10.1016/j.biomaterials.2015.09.035 ↗
8. Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct valvular interstitial cell phenotype in a three-dimensional environment10.1016/j.biomaterials.2015.01.047 ↗
9. Reversed-engineered human alveolar lung-on-a-chip model10.1073/pnas.2016146118 ↗
10. Tumor-like lung cancer model based on 3D bioprinting10.1007/s13205-018-1519-1 ↗
11. 3D printed hydrogels with oxidized cellulose nanofibers and silk fibroin for the proliferation of lung epithelial stem cells10.1007/s10570-020-03526-7 ↗
12. Alveolar epithelial cells and microenvironmental stiffness synergistically drive fibroblast activation in three-dimensional hydrogel lung models10.1039/D2BM00827K ↗
13. A two-step bioreactor for decellularized lung epithelialization10.1159/000517622 ↗
14. Recent advances in lung-on-a-chip models10.1016/j.drudis.2022.06.004 ↗
15. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility10.1016/j.biomaterials.2009.08.055 ↗
16. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes10.1089/ten.tea.2009.0232 ↗
17. The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs10.1016/j.biomaterials.2013.01.028 ↗
18. Wagner · 2014
19. Extracellular matrix-based biomaterials and their influence upon cell behavior10.1007/s10439-019-02408-9 ↗
20. Clickable decellularized extracellular matrix as a new tool for building hybrid-hydrogels to model chronic fibrotic diseases in vitro10.1039/D0TB00613K ↗
21. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration10.1016/j.biomaterials.2013.11.078 ↗
22. Human lung extracellular matrix hydrogels resemble the stiffness and viscoelasticity of native lung tissue10.1152/ajplung.00451.2019 ↗
23. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation10.1164/rccm.201204-0754OC ↗
24. Porcine lung-derived extracellular matrix hydrogel properties are dependent on pepsin digestion time10.1089/ten.tec.2020.0042 ↗
25. Development and characterization of a naturally derived lung extracellular matrix hydrogel10.1002/jbm.a.35726 ↗
26. Decellularized extracellular matrix hydrogels—cell behavior as a function of matrix stiffness10.1016/j.cobme.2019.05.002 ↗
27. Controlling stem cell behavior with decellularized extracellular matrix scaffolds10.1016/j.cossms.2016.02.001 ↗
28. Tunable hydrogels from pulmonary extracellular matrix for 3D cell culture
29. Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity10.1016/j.actbio.2015.08.040 ↗
30. A hydrogel derived from decellularized dermal extracellular matrix10.1016/j.biomaterials.2012.06.051 ↗
31. Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells10.1021/acsami.5b03195 ↗
32. Tailoring mechanical properties of decellularized extracellular matrix bioink by vitamin B2-induced photo-crosslinking10.1016/j.actbio.2016.01.013 ↗
33. A biological functional hybrid scaffold based on decellularized extracellular matrix/gelatin/chitosan with high biocompatibility and antibacterial activity for skin tissue engineering10.1016/j.ijbiomac.2021.07.162 ↗
34. Development and characterization of a naturally derived lung extracellular matrix hydrogel10.1002/jbm.a.35726 ↗
35. Characterisation of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies10.1016/j.biomaterials.2006.01.026 ↗
36. The Hertz model in AFM nanoindentation experiments: applications in biological samples and biomaterials
37. Synthesis and characterization of elastic and macroporous chitosan–gelatin cryogels for tissue engineering10.1016/j.actbio.2008.07.009 ↗
38. Injectable, porous, and cell-responsive gelatin cryogels10.1016/j.biomaterials.2013.11.044 ↗
39. Regional and disease specific human lung extracellular matrix composition10.1016/j.biomaterials.2022.121960 ↗
40. Quantification of extracellular matrix proteins from a rat lung scaffold to provide a molecular readout for tissue engineering10.1074/mcp.M114.045260 ↗
41. Collagen type XIV is proportionally lower in the lung tissue of patients with IPF10.1038/s41598-023-46733-5 ↗
42. A noninvasive ultrasound elastography technique for measuring surface waves on the lung10.1016/j.ultras.2016.06.012 ↗
43. Cross-platform mechanical characterization of lung tissue10.1371/journal.pone.0204765 ↗
44. Cavitation rheology for soft materials
45. Three-dimensional supermacroporous carrageenan-gelatin cryogel matrix for tissue engineering applications10.1155/2013/478279 ↗
46. Elastic and macroporous agarose–gelatin cryogels with isotropic and anisotropic porosity for tissue engineering10.1002/jbm.a.32127 ↗
47. S. Van Vlierberghe, P. Dubruel, and E. Schacht, “Effect of Cryogenic Treatment on the Rheological Properties of Gelatin Hydrogels”, doi: 10.1177/0883911510377254.10.1177/0883911510377254 ↗
48. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease10.1183/13993003.01805-2016 ↗
49. Proteoglycans and Sulfated Glycosaminoglycans